key: cord-0017223-ppqxs09z
authors: Tanios, Maged; Nguyen, Huan Mark; Le, Quang A.; Park, Hyunsoon; Devlin, John W.
title: Fentanyl- and midazolam-induced coma each influence days of mechanical ventilation and 28-day mortality
date: 2021-05-05
journal: Intensive Care Med
DOI: 10.1007/s00134-021-06418-x
sha: 753f9af12629eec58f3f43fa7a3cdc7999b4a9f9
doc_id: 17223
cord_uid: ppqxs09z

nan

propofol; it was weaned off in four patients in < 6 h. Daily propofol exposure in the CF patients was converted to midazolam dose equivalents.

Age, APACHE-II score, coma (RASS = − 4 or − 5) occurrence and its duration, days free of mechanical ventilation at 28 days, and 28-day mortality were not statistically different between the CF and CM groups (Table 1) . Compared to the CM group, patients in the CF group received significantly more daily fentanyl (P = 0.05) and significantly less sedation (P < 0.001). On coma (vs. no coma) days, across both CF and CM groups, daily use of fentanyl (median 972.4 vs. 224.6 mcg, P = 0.02) and midazolam (median 14.2 vs. 3.3 mg, P = 0.009) were greater on coma days. Among patients who developed coma, the presence of ≥ 1 baseline neurologic condition was similar between CF (vs. no CM) [3(33.3%) vs.7(26.9%) P = 0.54) groups.

Separate multivariable logistic regression models controlling for age, APACHE-II score, daily fentanyl, daily gabaminergic sedation exposure, CF (vs. CM) group allocation, and coma occurrence was constructed for each clinical outcome (i.e., days free of mechanical ventilation in 28-days and mortality in 28-days). We found coma was the only variable independently associated with more days of mechanical ventilation (OR = 2.0, 95% CI 1.43-23.1, P = 0.02) or greater mortality (OR = 5.9, 95% CI 1.4-25.5; P = 0.01) at 28-days regardless of whether patients were allocated to the CF or CM groups.

Our results suggest the effect of medication-associated coma on days spent on mechanical ventilation or 28-day mortality is similar regardless of whether the coma is related to an analgosedation or gabaminergic sedative management approach. Until future prospective research is conducted to confirm our results, clinicians should optimize strategies to maintain patient wakefulness and reduce patient-ventilator asynchrony in mechanically ventilated adults and consider alternatives to opioid and gabaminergic sedatives including non-opioid analgesics, dexmedetomidine, and inhaled anesthetics [5] (Table 1) . 

Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU

Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial

The impact of analgosedation on mortality and delirium in critically ill patients: a systematic review and meta-analysis

Analgesia-first sedation in critically ill adults: A U.S. pilot, randomized controlled trial

Analgesia and sedation in patients with ARDS